Transient endothelial dysfunction following flow-mediated dilation assessment

Roberto Nerla, Antonio Di Monaco, Alfonso Sestito, Priscilla Lamendola, Enrico Di Stasio, Federica Romitelli, Gaetano Antonio Lanza, Filippo Crea

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Flow-mediated dilation (FMD) is a widely used tool to investigate endothelial function. However, FMD assessment may cause mechanical damage to the arterial endothelium. In this study we investigated the effect of FMD assessment on endothelial function. We studied 20 healthy subjects (26 ± 6 years; 12 males). FMD was assessed by measuring brachial artery dilation in response to hyperemia after 5 min of forearm cuff inflation. Subjects were studied on 2 subsequent days. On day 1 they underwent two consecutive FMD measures, with the second test (FMD2) performed 15 min after the first test (FMD1). On day 2, the subjects were randomized to receive either placebo (saline) or intravenous L-arginine (10 g in 20 min). At the end of the infusion, patients underwent two consecutive FMD measures following the same protocol as on day 1. Asymmetric dimethyl-arginine (ADMA) serum levels were assessed on day 2 before FMD1 and FMD2. On day 1, FMD2 was lower than FMD1 in both groups (placebo 6.47 ± 2.1 vs. 7.86 ± 1.8%, P <0.01; arginine 6.13 ± 2.6 vs. 7.76 ± 2.7%, P <0.01). On day 2, a significant reduction of FMD was observed during FMD2 compared to FMD1 in the placebo group (5.82 ± 1.7 vs. 7.44 ± 2.2%, P <0.001), but not in the arginine group (7.19 ± 1.5 vs. 7.27 ± 1.5, P = 0.67). ADMA levels significantly increased compared to baseline after FMD1 (0.59 ± 0.12-0.91 ± 0.64 μmol/l, P = 0.036), with similar changes in the two groups. FMD assessment induces a significant impairment of endothelial function. An increase of endogenous NO synthesis inhibitors seems responsible for the phenomenon that is reversed by L-arginine administration.

Original languageEnglish
Pages (from-to)524-529
Number of pages6
JournalHeart and Vessels
Volume26
Issue number5
DOIs
Publication statusPublished - 2011

Fingerprint

Dilatation
Arginine
Placebos
Brachial Artery
Hyperemia
Economic Inflation
Forearm
Endothelium
Healthy Volunteers
Serum

Keywords

  • Arginine
  • Endothelial function
  • Flow mediated dilation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Nerla, R., Di Monaco, A., Sestito, A., Lamendola, P., Di Stasio, E., Romitelli, F., ... Crea, F. (2011). Transient endothelial dysfunction following flow-mediated dilation assessment. Heart and Vessels, 26(5), 524-529. https://doi.org/10.1007/s00380-010-0087-z

Transient endothelial dysfunction following flow-mediated dilation assessment. / Nerla, Roberto; Di Monaco, Antonio; Sestito, Alfonso; Lamendola, Priscilla; Di Stasio, Enrico; Romitelli, Federica; Lanza, Gaetano Antonio; Crea, Filippo.

In: Heart and Vessels, Vol. 26, No. 5, 2011, p. 524-529.

Research output: Contribution to journalArticle

Nerla, R, Di Monaco, A, Sestito, A, Lamendola, P, Di Stasio, E, Romitelli, F, Lanza, GA & Crea, F 2011, 'Transient endothelial dysfunction following flow-mediated dilation assessment', Heart and Vessels, vol. 26, no. 5, pp. 524-529. https://doi.org/10.1007/s00380-010-0087-z
Nerla R, Di Monaco A, Sestito A, Lamendola P, Di Stasio E, Romitelli F et al. Transient endothelial dysfunction following flow-mediated dilation assessment. Heart and Vessels. 2011;26(5):524-529. https://doi.org/10.1007/s00380-010-0087-z
Nerla, Roberto ; Di Monaco, Antonio ; Sestito, Alfonso ; Lamendola, Priscilla ; Di Stasio, Enrico ; Romitelli, Federica ; Lanza, Gaetano Antonio ; Crea, Filippo. / Transient endothelial dysfunction following flow-mediated dilation assessment. In: Heart and Vessels. 2011 ; Vol. 26, No. 5. pp. 524-529.
@article{7ab29f86031a4f8a906f3964f8fb01f2,
title = "Transient endothelial dysfunction following flow-mediated dilation assessment",
abstract = "Flow-mediated dilation (FMD) is a widely used tool to investigate endothelial function. However, FMD assessment may cause mechanical damage to the arterial endothelium. In this study we investigated the effect of FMD assessment on endothelial function. We studied 20 healthy subjects (26 ± 6 years; 12 males). FMD was assessed by measuring brachial artery dilation in response to hyperemia after 5 min of forearm cuff inflation. Subjects were studied on 2 subsequent days. On day 1 they underwent two consecutive FMD measures, with the second test (FMD2) performed 15 min after the first test (FMD1). On day 2, the subjects were randomized to receive either placebo (saline) or intravenous L-arginine (10 g in 20 min). At the end of the infusion, patients underwent two consecutive FMD measures following the same protocol as on day 1. Asymmetric dimethyl-arginine (ADMA) serum levels were assessed on day 2 before FMD1 and FMD2. On day 1, FMD2 was lower than FMD1 in both groups (placebo 6.47 ± 2.1 vs. 7.86 ± 1.8{\%}, P <0.01; arginine 6.13 ± 2.6 vs. 7.76 ± 2.7{\%}, P <0.01). On day 2, a significant reduction of FMD was observed during FMD2 compared to FMD1 in the placebo group (5.82 ± 1.7 vs. 7.44 ± 2.2{\%}, P <0.001), but not in the arginine group (7.19 ± 1.5 vs. 7.27 ± 1.5, P = 0.67). ADMA levels significantly increased compared to baseline after FMD1 (0.59 ± 0.12-0.91 ± 0.64 μmol/l, P = 0.036), with similar changes in the two groups. FMD assessment induces a significant impairment of endothelial function. An increase of endogenous NO synthesis inhibitors seems responsible for the phenomenon that is reversed by L-arginine administration.",
keywords = "Arginine, Endothelial function, Flow mediated dilation",
author = "Roberto Nerla and {Di Monaco}, Antonio and Alfonso Sestito and Priscilla Lamendola and {Di Stasio}, Enrico and Federica Romitelli and Lanza, {Gaetano Antonio} and Filippo Crea",
year = "2011",
doi = "10.1007/s00380-010-0087-z",
language = "English",
volume = "26",
pages = "524--529",
journal = "Heart and Vessels",
issn = "0910-8327",
publisher = "Springer Japan",
number = "5",

}

TY - JOUR

T1 - Transient endothelial dysfunction following flow-mediated dilation assessment

AU - Nerla, Roberto

AU - Di Monaco, Antonio

AU - Sestito, Alfonso

AU - Lamendola, Priscilla

AU - Di Stasio, Enrico

AU - Romitelli, Federica

AU - Lanza, Gaetano Antonio

AU - Crea, Filippo

PY - 2011

Y1 - 2011

N2 - Flow-mediated dilation (FMD) is a widely used tool to investigate endothelial function. However, FMD assessment may cause mechanical damage to the arterial endothelium. In this study we investigated the effect of FMD assessment on endothelial function. We studied 20 healthy subjects (26 ± 6 years; 12 males). FMD was assessed by measuring brachial artery dilation in response to hyperemia after 5 min of forearm cuff inflation. Subjects were studied on 2 subsequent days. On day 1 they underwent two consecutive FMD measures, with the second test (FMD2) performed 15 min after the first test (FMD1). On day 2, the subjects were randomized to receive either placebo (saline) or intravenous L-arginine (10 g in 20 min). At the end of the infusion, patients underwent two consecutive FMD measures following the same protocol as on day 1. Asymmetric dimethyl-arginine (ADMA) serum levels were assessed on day 2 before FMD1 and FMD2. On day 1, FMD2 was lower than FMD1 in both groups (placebo 6.47 ± 2.1 vs. 7.86 ± 1.8%, P <0.01; arginine 6.13 ± 2.6 vs. 7.76 ± 2.7%, P <0.01). On day 2, a significant reduction of FMD was observed during FMD2 compared to FMD1 in the placebo group (5.82 ± 1.7 vs. 7.44 ± 2.2%, P <0.001), but not in the arginine group (7.19 ± 1.5 vs. 7.27 ± 1.5, P = 0.67). ADMA levels significantly increased compared to baseline after FMD1 (0.59 ± 0.12-0.91 ± 0.64 μmol/l, P = 0.036), with similar changes in the two groups. FMD assessment induces a significant impairment of endothelial function. An increase of endogenous NO synthesis inhibitors seems responsible for the phenomenon that is reversed by L-arginine administration.

AB - Flow-mediated dilation (FMD) is a widely used tool to investigate endothelial function. However, FMD assessment may cause mechanical damage to the arterial endothelium. In this study we investigated the effect of FMD assessment on endothelial function. We studied 20 healthy subjects (26 ± 6 years; 12 males). FMD was assessed by measuring brachial artery dilation in response to hyperemia after 5 min of forearm cuff inflation. Subjects were studied on 2 subsequent days. On day 1 they underwent two consecutive FMD measures, with the second test (FMD2) performed 15 min after the first test (FMD1). On day 2, the subjects were randomized to receive either placebo (saline) or intravenous L-arginine (10 g in 20 min). At the end of the infusion, patients underwent two consecutive FMD measures following the same protocol as on day 1. Asymmetric dimethyl-arginine (ADMA) serum levels were assessed on day 2 before FMD1 and FMD2. On day 1, FMD2 was lower than FMD1 in both groups (placebo 6.47 ± 2.1 vs. 7.86 ± 1.8%, P <0.01; arginine 6.13 ± 2.6 vs. 7.76 ± 2.7%, P <0.01). On day 2, a significant reduction of FMD was observed during FMD2 compared to FMD1 in the placebo group (5.82 ± 1.7 vs. 7.44 ± 2.2%, P <0.001), but not in the arginine group (7.19 ± 1.5 vs. 7.27 ± 1.5, P = 0.67). ADMA levels significantly increased compared to baseline after FMD1 (0.59 ± 0.12-0.91 ± 0.64 μmol/l, P = 0.036), with similar changes in the two groups. FMD assessment induces a significant impairment of endothelial function. An increase of endogenous NO synthesis inhibitors seems responsible for the phenomenon that is reversed by L-arginine administration.

KW - Arginine

KW - Endothelial function

KW - Flow mediated dilation

UR - http://www.scopus.com/inward/record.url?scp=84855722445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855722445&partnerID=8YFLogxK

U2 - 10.1007/s00380-010-0087-z

DO - 10.1007/s00380-010-0087-z

M3 - Article

VL - 26

SP - 524

EP - 529

JO - Heart and Vessels

JF - Heart and Vessels

SN - 0910-8327

IS - 5

ER -